| Literature DB >> 34202721 |
Sheng-Chieh Wang1, Ruei-Nian Li1, Li-Ching Lin2,3,4, Jen-Yang Tang5,6, Jui-Hsin Su7,8, Jyh-Horng Sheu9,10,11,12, Hsueh-Wei Chang1,13,14,15,16.
Abstract
Marine natural products are abundant resources for antioxidants, but the antioxidant property of the soft corals-derived sinularin and dihydrosinularin were unknown. This study aimed to assess antioxidant potential and antiproliferation effects of above compounds on cancer cells, and to investigate the possible relationships between them. Results show that sinularin and dihydrosinularin promptly reacted with 2,2-diphenyl-1-picrylhydrazyl (DPPH), 2,2-azinobis (3-ethyl-benzothiazoline-6-sulfonic acid) (ABTS), and hydroxyl (•OH), demonstrating a general radical scavenger activity. Sinularin and dihydrosinularin also show an induction for Fe+3-reduction and Fe+2-chelating capacity which both strengthen their antioxidant activities. Importantly, sinularin shows higher antioxidant properties than dihydrosinularin. Moreover, 24 h ATP assays show that sinularin leads to higher antiproliferation of breast, lung, and liver cancer cells than dihydrosinularin. Therefore, the differential antioxidant properties of sinularin and dihydrosinularin may contribute to their differential anti-proliferation of different cancer cells.Entities:
Keywords: antioxidant; cytotoxicity; dihydrosinularin; marine natural products; sinularin; soft coral
Mesh:
Substances:
Year: 2021 PMID: 34202721 PMCID: PMC8270243 DOI: 10.3390/molecules26133853
Source DB: PubMed Journal: Molecules ISSN: 1420-3049 Impact factor: 4.411
Figure 1Structures and DPPH scavenging activities of sinularin and dihydrosinularin. (A) Structures. (B) DPPH scavenging activities. Data, mean ± SD (n = 3). DPPH scavenging activities for different concentrations of sinularin (SINU) and dihydrosinularin (DHSI) are compared to blank. According to multiple comparisons, data of the same characters showing non-overlap indicate significant differences (p < 0.05–0.001).
Figure 2ABTS scavenging activities of sinularin and dihydrosinularin. Data, mean ± SD (n = 3). DPPH scavenging activities for different concentrations of sinularin (SINU) and dihydrosinularin (DHSI) are compared to blank. According to multiple comparisons, data of the same characters showing non-overlap indicate significant differences (p < 0.05–0.001).
Figure 3Hydroxyl scavenging activities of sinularin and dihydrosinularin. Data, mean ± SD (n = 3). DPPH scavenging activities for different concentrations of sinularin (SINU) and dihydrosinularin (DHSI) are compared to blank. According to multiple comparisons, data of the same characters showing non-overlap indicate significant differences (p < 0.05–0.001).
Figure 4Ferric ions-reducing powers of sinularin and dihydrosinularin. Data, mean ± SD (n = 3). Ferric ions-reducing powers for different concentrations of sinularin (SINU) and dihydrosinularin (DHSI) are compared to blank. According to multiple comparisons, data of the same characters showing non-overlap indicate significant differences (p < 0.05–0.001).
Figure 5Ferrous ions-chelating capacities of sinularin and dihydrosinularin. Data, mean ± SD (n = 3). Ferrous ions-chelating capacities for different concentrations of sinularin (SINU) and dihydrosinularin (DHSI) are compared to blank. According to multiple comparisons, data of the same characters showing non-overlap indicate significant differences (p < 0.05–0.001).
Figure 6Cell viability of triple-negative breast and liver cancer cells following sinularin and dihydrosinularin treatments. Breast MDA-MB-231, lung H1299, and liver Ha22T cancer cells were treated with sinularin (SINU) and dihydrosinularin (DHSI) for 24 h incubation. Subsequently, their viabilities were determined by ATP assay (data, mean ± SD (n = 3)). According to multiple comparisons, data of the same characters showing non-overlap indicate significant differences (p < 0.05–0.001).